This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Benzinga24minutes ago

Aclaris Therapeutics Raised to Outperform From Market Perform by Leerink Partners

Dow JonesNov 19 08:42 ET · Ratings

A Quick Look at Today's Ratings for Aclaris Therapeutics(ACRS.US), With a Forecast Between $3 to $13

Moomoo NewsNov 19 08:00 ET · Ratings

Promising Potential of Aclaris Therapeutics' BSI-045B and Pipeline Elevates Buy Rating

TipRanksNov 19 05:16 ET · Ratings

Aclaris Therapeutics Positioned for Growth With Strategic Acquisition and Promising Pipeline

TipRanksNov 19 05:16 ET

BTIG Upgrades Aclaris Therapeutics to Buy, Announces $8 Price Target

BenzingaNov 19 04:46 ET · Ratings